158 related articles for article (PubMed ID: 24961944)
1. Management impact of FDG-PET in dementia: results from a tertiary center memory clinic.
Elias A; Woodward M; Rowe CC
J Alzheimers Dis; 2014; 42(3):885-92. PubMed ID: 24961944
[TBL] [Abstract][Full Text] [Related]
2. Impact of (18)FDG PET and (11)C-PIB PET brain imaging on the diagnosis of Alzheimer's disease and other dementias in a regional memory clinic in Hong Kong.
Shea YF; Ha J; Lee SC; Chu LW
Hong Kong Med J; 2016 Aug; 22(4):327-33. PubMed ID: 27313272
[TBL] [Abstract][Full Text] [Related]
3. Clinical Impact of a Second FDG-PET in Atypical/Unclear Dementia Syndromes.
Bergeron D; Beauregard JM; Guimond J; Fortin MP; Houde M; Poulin S; Verret L; Bouchard RW; Laforce R
J Alzheimers Dis; 2016; 49(3):695-705. PubMed ID: 26484904
[TBL] [Abstract][Full Text] [Related]
4. Impact of molecular imaging on the diagnostic process in a memory clinic.
Ossenkoppele R; Prins ND; Pijnenburg YA; Lemstra AW; van der Flier WM; Adriaanse SF; Windhorst AD; Handels RL; Wolfs CA; Aalten P; Verhey FR; Verbeek MM; van Buchem MA; Hoekstra OS; Lammertsma AA; Scheltens P; van Berckel BN
Alzheimers Dement; 2013 Jul; 9(4):414-21. PubMed ID: 23164552
[TBL] [Abstract][Full Text] [Related]
5. European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain
Nobili F; Arbizu J; Bouwman F; Drzezga A; Agosta F; Nestor P; Walker Z; Boccardi M;
Eur J Neurol; 2018 Oct; 25(10):1201-1217. PubMed ID: 29932266
[TBL] [Abstract][Full Text] [Related]
6. Brain 18F-FDG-PET: Utility in the Diagnosis of Dementia and Epilepsy.
Lotan E; Friedman KP; Davidson T; Shepherd TM
Isr Med Assoc J; 2020 Mar; 22(3):178-184. PubMed ID: 32147984
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic impact of [
Zwan MD; Bouwman FH; Konijnenberg E; van der Flier WM; Lammertsma AA; Verhey FR; Aalten P; van Berckel BN; Scheltens P
Alzheimers Res Ther; 2017 Jan; 9(1):2. PubMed ID: 28093088
[TBL] [Abstract][Full Text] [Related]
8. Utility of Amyloid and FDG-PET in Clinical Practice: Differences Between Secondary and Tertiary Care Memory Units.
Lage C; Suarez AG; Pozueta A; Riancho J; Kazimierczak M; Bravo M; Jimenez Bonilla J; de Arcocha Torres M; Quirce R; Banzo I; Vazquez-Higuera JL; Rabinovici GD; Rodriguez-Rodriguez E; Sánchez-Juan P
J Alzheimers Dis; 2018; 63(3):1025-1033. PubMed ID: 29710706
[TBL] [Abstract][Full Text] [Related]
9. Fluorodeoxyglucose-positron emission tomography in the differential diagnosis of early-onset dementia: a prospective, community-based study.
Panegyres PK; Rogers JM; McCarthy M; Campbell A; Wu JS
BMC Neurol; 2009 Aug; 9():41. PubMed ID: 19674446
[TBL] [Abstract][Full Text] [Related]
10. Amyloid imaging for differential diagnosis of dementia: incremental value compared to clinical diagnosis and [
Hellwig S; Frings L; Bormann T; Vach W; Buchert R; Meyer PT
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):312-323. PubMed ID: 30094462
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact and diagnostic accuracy of 2-[
Motara H; Olusoga T; Russell G; Jamieson S; Ahmed S; Brindle N; Pillai A; Scarsbrook AF; Patel CN; Chowdhury FU
Clin Radiol; 2017 Jan; 72(1):63-73. PubMed ID: 27637430
[TBL] [Abstract][Full Text] [Related]
12. Hybrid FDG PET/MRI vs. FDG PET and CT in patients with suspected dementia - A comparison of diagnostic yield and propagated influence on clinical diagnosis and patient management.
Kaltoft NS; Marner L; Larsen VA; Hasselbalch SG; Law I; Henriksen OM
PLoS One; 2019; 14(5):e0216409. PubMed ID: 31048902
[TBL] [Abstract][Full Text] [Related]
13. Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers.
Bensaïdane MR; Beauregard JM; Poulin S; Buteau FA; Guimond J; Bergeron D; Verret L; Fortin MP; Houde M; Bouchard RW; Soucy JP; Laforce R
J Alzheimers Dis; 2016 Apr; 52(4):1251-62. PubMed ID: 27104896
[TBL] [Abstract][Full Text] [Related]
14. Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort: The ABIDE Project.
de Wilde A; van der Flier WM; Pelkmans W; Bouwman F; Verwer J; Groot C; van Buchem MM; Zwan M; Ossenkoppele R; Yaqub M; Kunneman M; Smets EMA; Barkhof F; Lammertsma AA; Stephens A; van Lier E; Biessels GJ; van Berckel BN; Scheltens P
JAMA Neurol; 2018 Sep; 75(9):1062-1070. PubMed ID: 29889941
[TBL] [Abstract][Full Text] [Related]
15. Brain FDG PET and the diagnosis of dementia.
Shivamurthy VK; Tahari AK; Marcus C; Subramaniam RM
AJR Am J Roentgenol; 2015 Jan; 204(1):W76-85. PubMed ID: 25539279
[TBL] [Abstract][Full Text] [Related]
16. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.
Foster NL; Heidebrink JL; Clark CM; Jagust WJ; Arnold SE; Barbas NR; DeCarli CS; Turner RS; Koeppe RA; Higdon R; Minoshima S
Brain; 2007 Oct; 130(Pt 10):2616-35. PubMed ID: 17704526
[TBL] [Abstract][Full Text] [Related]
17. Autopsy as gold standard in FDG-PET studies in dementia.
Durand-Martel P; Tremblay D; Brodeur C; Paquet N
Can J Neurol Sci; 2010 May; 37(3):336-42. PubMed ID: 20481267
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of FDG-PET and HMPAO-SPET in patients with mild dementia and mild cognitive impairment: metabolic index and perfusion index.
Döbert N; Pantel J; Frölich L; Hamscho N; Menzel C; Grünwald F
Dement Geriatr Cogn Disord; 2005; 20(2-3):63-70. PubMed ID: 15908747
[TBL] [Abstract][Full Text] [Related]
19. Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET.
Brendel M; Schnabel J; Schönecker S; Wagner L; Brendel E; Meyer-Wilmes J; Unterrainer M; Schildan A; Patt M; Prix C; Ackl N; Catak C; Pogarell O; Levin J; Danek A; Buerger K; Bartenstein P; Barthel H; Sabri O; Rominger A
Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2239-2248. PubMed ID: 28932894
[TBL] [Abstract][Full Text] [Related]
20. Guidance for reading FDG PET scans in dementia patients.
Herholz K
Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):332-43. PubMed ID: 25391316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
